Nasic (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline Hydrochloride, the active ingredient in Nasic, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, acute rhinitis and sinusitis in adults and children.

GNH USA supplies Nasic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasic acts on the nasal mucosa to reduce swelling and improve airflow in common upper‑respiratory conditions.

Nasal congestion due to common cold: provides rapid decongestion and easier breathing. Acute rhinitis: reduces mucosal swelling and nasal blockage. Sinusitis‑associated nasal blockage: eases obstruction and supports sinus drainage.

Nasic may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing or mild nosebleeds - Headache - Altered taste or bitter after‑taste - Mild dizziness

Serious or Rare Side Effects: - Severe epistaxis (heavy nosebleed) - Allergic reactions such as rash, itching, or angioedema - Paradoxical worsening of congestion (rebound congestion) - Nasal ulceration or perforation with prolonged use - Anaphylaxis (rare but life‑threatening) - Vision changes if spray contacts the eyes

Before using Nasic, consider the following safety measures.

Pregnancy: consult a healthcare professional as safety data are limited. Breastfeeding: discuss potential risks with a physician. Age restrictions: not recommended for children under 2 years of age. Pre‑existing nasal conditions: avoid if severe septal deviation, recent nasal surgery, or chronic rhinitis. Concurrent nasal medications: limit use with other decongestants to prevent excessive vasoconstriction. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasic can interact with other agents that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Other nasal decongestants: risk of excessive vasoconstriction and rebound congestion. - Monoamine oxidase inhibitors (MAOIs): theoretical risk of hypertensive episodes. - Systemic sympathomimetics: additive cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: possible reduction in blood‑pressure‑lowering effect. - Topical nasal steroids: monitor for increased local irritation. - Alcohol or sedatives: may enhance dizziness or drowsiness.